Delays in patient recruitment don’t just impact timelines. They put entire development programs at risk. Addressing an underperforming trial requires careful, high-stakes decisions. The wrong approach can create disruption. The right one stabilizes your trial and protects your investment.
SCIRENT specializes in structured trial rescue and recovery with a focus on recruitment turnaround, seamless transition, and regulatory integrity for cardiology trials.
Recruitment significantly below forecast
Underperforming or inactive sites
Missed milestones and escalating costs
Internal pressure to “fix or terminate”
We help you regain control with a clear, data-driven recovery strategy.
We don’t start with assumptions. We start with evidence. Our rapid diagnostic is designed to identify the true causes of underperformance and create a clear path forward.
We analyze the full recruitment funnel, from screening to enrollment and drop-offs, to pinpoint where patients are lost. This analysis is led by experienced site specialists and medical experts in our company, including physicians with hands-on experience as principal investigators, ensuring that both operational and clinical realities are fully reflected. Site performance is benchmarked to identify operational gaps, while protocol complexity and patient burden are assessed for potential barriers to participation. In parallel, we re-evaluate feasibility across geographies based on patient availability, standards of care, and competitive trials.
The result is a transparent, data-driven recovery plan that replaces guesswork with clarity.
Cardiology trials often involve complex procedures, imaging, and highly specialized sites. When performance declines, the priority is to stabilize the study while maintaining data consistency and compliance.
Where possible, we work within your existing setup by strengthening site performance, adding targeted support, or expanding your site network. If a transition becomes necessary and represents the best path forward, we manage it in a structured and controlled way to minimize disruption.
Our approach includes a dedicated transition team for the critical first 30 to 60 days, ensuring continuity of imaging, diagnostics, and endpoint assessment, as well as secure data transfer and validated systems. High-performing cardiology sites are retained and supported, while additional experienced cardiovascular centers can be onboarded as needed.
Your study continues with full control over data quality and compliance.
Recruitment in cardiology depends on access, timing, and trust.
Rescuing a cardiovascular trial requires more than operational expertise. It requires a deep understanding of the clinical realities that drive recruitment challenges. SCIRENT works as an extension of your team, aligning clinical, operational, and regulatory stakeholders while maintaining clear and proactive communication. In high-pressure situations, honest, data-driven recommendations are essential, and that is exactly what we provide.
The earlier you act, the more options you have to recover your trial. Request a confidential study assessment. We’ll provide an initial diagnostic and outline potential recovery scenarios tailored to your indication.
